Avex Pharma Semaglutide

Semaglutide is an advanced GLP-1 (glucagon-like peptide-1) receptor agonist designed to mimic the natural hormone GLP-1, which helps control blood sugar levels, reduce appetite, and support metabolic health. It enhances insulin secretion when blood glucose levels are high, slows gastric emptying, and suppresses glucagon production — resulting in better glycemic control and sustainable weight loss.

Commonly prescribed for type 2 diabetes and weight management, Semaglutide can be used as part of a broader treatment plan involving diet and exercise. It is available in both injectable and oral forms and has become one of the leading treatments for long-term metabolic improvement.

Key Benefits:

• Improves blood sugar control in type 2 diabetes

• Promotes significant and sustained weight loss

• Reduces appetite and food cravings

• Lowers HbA1c levels and supports metabolic health

• Clinically proven and FDA-approved GLP-1 receptor agonist

Dosage & Administration:
Administer Semaglutide as directed by a healthcare provider, typically once weekly via subcutaneous injection. Dosage is gradually increased to minimize side effects such as nausea or gastrointestinal discomfort.

Precautions:

• Use only under medical supervision.

• Not suitable for individuals with a history of pancreatitis or thyroid cancer.

• Store refrigerated and protect from light.